TcLand Expression Will Receive 1.2 Million Euros from Oseo and ERDF to Support a Leading Project in Personalised Medicine Focused on Rheumatoid Arthritis
6/17/2011 8:30:56 AM
More...
|
TcLand Expression's Board of Directors Appoints Highly Qualified Personalized Medicine Expert Felix Frueh Phd, as New Board Member
4/19/2011 9:23:32 AM
More...
|
TcLand Expression is Part of the Innovative Medicines Initiative "Be The CURE", the Largest European Consortium for Rheumatology
3/22/2011 9:30:54 AM
More...
|
TcLand Expression Launches the "PRINT" International Clinical Trial to Validate its Blood Biomarker RA-INF-Dx and Announces the Recruitment of its First Patient
2/22/2011 9:41:01 AM
More...
|
TcLand Expression Appoints its Scientific and Medical Advisory Board Dedicated to Rheumatology
1/13/2011 10:26:50 AM
More...
|
TcLand Expression Strengthens Its Senior Management Team by Appointing Peter Payne as Chief Business Officer and Head of US Operations
12/20/2010 11:13:24 AM
More...
|
TcLand Expression Signs A Licensing Agreement With Inserm Transfert And Initiates A Strategic Collaboration On The Development Of Companion Diagnostic Tests For Rheumatoid Arthritis Therapies
7/7/2010 12:52:40 PM
More...
|
TcLand Expression And Its Collaborative Partners Receive €450,000 (552,000 USD) In Funding From The French National Research Agency For The Company's Companion Diagnostic Program In Rheumatoid Arthritis.
5/27/2010 11:12:23 AM
More...
|
TcLand Expression Launches An International, Multicenter Clinical Validation Study
10/13/2009 1:54:09 PM
More...
|
TcLand Expression, A World Leader In The Field Of Gene Expression Biomarkers In Immunology, Receives €1.8 Million In Innovation Support From Oseo
4/28/2009 1:50:45 PM
More...
|
|